Abstract:Bleeding complications arising from trauma, surgery, and as congenital, disease-associated, or drug-induced blood disorders can cause significant morbidities and mortalities in civilian and military populations. Therefore, stoppage of bleeding (hemostasis) is of paramount clinical significance in prophylactic, surgical, and emergency scenarios. For externally accessible injuries, a variety of natural and synthetic biomaterials have undergone robust research, leading to hemostatic technologies including glues, bandages, tamponades, tourniquets, dressings, and procoagulant powders. In contrast, treatment of internal noncompressible hemorrhage still heavily depends on transfusion of whole blood or blood's hemostatic components (platelets, fibrinogen, and coagulation factors). Transfusion of platelets poses significant challenges of limited availability, high cost, contamination risks, short shelf-life, low portability, performance variability, and immunological side effects, while use of fibrinogen or coagulation factors provides only partial mechanisms for hemostasis. With such considerations, significant interdisciplinary research endeavors have been focused on developing materials and technologies that can be manufactured conveniently, sterilized to minimize contamination and enhance shelf-life, and administered intravenously to mimic, leverage, and amplify physiological hemostatic mechanisms. Here, a comprehensive review regarding the various topical, intracavitary, and intravenous hemostatic technologies in terms of materials, mechanisms, and state-of-art is provided, and challenges and opportunities to help advancement of the field are discussed.

Topical hemostatic materials for coagulopathy

Emerging materials for hemostasis

Research status and development potential of composite hemostatic materials.

Recent research advances on polysaccharide-, peptide-, and protein-based hemostatic materials: A review

Hemostasis Strategies and Recent Advances in Nanomaterials for Hemostasis

Advances of biological macromolecules hemostatic materials: A review

Preparation and Application of Hemostatic Microspheres Containing Biological Macromolecules and Others

Synergistic Procoagulant Mechanism and Application of Kaolin-Zeolite Composite Hemostat for Effective Hemorrhage Control

Hemostatic materials in wound care

Surface-functionalized design of blood-contacting biomaterials for preventing coagulation and promoting hemostasis

Preparation and Application of Hemostatic Hydrogels

Current status of hemostatic agents, their mechanism of action, and future directions

Haemostatic materials for wound healing applications

State of the art, trends, hotspots, and prospects of injection materials for controlling bleeding

Emerging hemostatic materials for non-compressible hemorrhage control

Nanomaterials: A Promising Material for Cardiac Hemostasis

Bioactive hydrogels with pro‐coagulation effect for hemostasis

Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding

STuning Blood‐Material Interactions to Generate Versatile Hemostatic Powders And Gels

Rational Design of Bioactive Materials for Bone Hemostasis and Defect Repair

Recent Advances on Synthetic and Polysaccharide Adhesives for Biological Hemostatic Applications